1.

Creutzig U, Cantu Rajnoldi A, Ritter J

classification. Br J Haematol 91:83-92,

et al : Myelodisplastic syndrome in

1985.
9. Yunis JJ, Lobell M, Arnesen MA, et al :

Childhood. Am. J. Ped Hematol/Oncol 9

: 325, 1987.
2. Silverman L

Refined chromosome study helps define

:

The

Myelodisplastic

prognostic soulgroups in most patient

Syndrome. In : Kufe D, Pollack R,

with

Weichselbaum R, et al. eds. Cancer

acute myelogenous leukemia. Br J

Medicine: Hamilton, ON BC Decker:

Haematol 98:189,1988.
10. Paydas S, Zorludemir S : Leukemia

2003:2077-2093.
3. Silverman LR, Demakos EP Peterson
BL et al : Randomized Controlled Triad
of Azaticidine in Patients with the
Myelodysplastic Syndromes : a study of
cancer and the leukemia group B. J Clin
Oncol 20:2429-2440,2002.
4. Fouchar K , Langdon RM II ArmitagoJO,
Olson DB, Carrol TJ Jr: Myelodysplastic
Syndromes:

clinical

pathologic

analysis of 109 cases. Cancer 59:553551,1985.

5. Mufti GJ Stevant JR< Oscier DG,
Hamblin TJ, Machin D : Myelodysplastic
Syndromes : A Scoring Systems with
Prognostic Significance. Br J Haematol
59: 425-432,1985.
6. Tricot G, Vlietinck R, Boogaerts MA, et
al

Prognostic

Factor

in

the

myelodysplastic syndromes : important

of initial data on peripheral blood counts,
bone marrow and cytology , trephine
biopsy and chromosomal analysis. Br J
Haematol 90:19-27,1985.
7. Varela BL, Chuang C, Woll JE, Bennet

myelodysplastic

syndrome

and

cutis and leukaemic vasculitis. Br J

Dermatol 143-773-779,2000.
11. Avivi I, Rosenbaum H, Levy Y, Rowe J :
Myelodysplastic

syndromes

and

associated skin lesion : a review of the

literatre. Leuk Res 23:323-330,1999.
12. Mergabene B, Bodemer C, Valensi F, et
al : Association of acute neuthrophilic
dermatosis

and

syndromes

with

myelodysplastic
(7;9)

chromosome

translocation: a case report and review

of literature. BJ Dermatol 143:13221324, 2000.
13. Enright H, Jacob HS, Vercellotti G,
Howe

R,

Belzer

M,

Miller

Paraneoplastic autoimmune phenomena

in

patients

with

syndromes

immunosuppressive

myelodysplastic
response
therapy.

to
Br

Haematol 91: 403-408,1995.

14. Tricot G, De Wolf Peeters

C,

Hendricks B, Verwilghen RL : Bone

Marrow Histology in myelodysplastic
syndromes:

histological

findings

JM: Modification in the classifications of

myelodysplastic

Primary Myelodisplastic syndromes: the

comparison with bone marrow smears.

additional

of

the

scoring

systems.

Haematol Oncol 3:55-95, 1985.

8. Vallespi T, Torrabadella M, Julia A, et al :

syndromes

in
and

Br J Haematol 57: 423,1984.

15. Tricot G, De Wplf Peeters C, Vlietinck
R, Verwilghen RL : Bone marrow

Myelodysplastic syndromes: a study of

histology in myelodysplastic syndromes:

101

Prognostic value of abnormallocalization

cases

according

to

the

FAB

of immature precursors in MDS. Br J

Haematol 58:217, 1984.
16. Mang MH, Salisbury JR, Mufti GJ :
Abnormal

localization

of

immature

associations

with

myelodysplastic

syndromes and other haemathologic

malignancy. Blood 105-443-452,2005.
24. Elghetany M, Mac Callum J, Nelson D et

precursors (ALIP) in the bone marrow

al.:

edge and future directions. Leuk. Res

myelodysplastic

syndromes

morphological,

cytochemical

15:927-939, 1984.
17. Tani K, Fujii H, Takahashi K, et al :
Erythrocyte

enzyme

activities

in

Abnormal

granulocytes

immunocytochemical

study

in
:

A
and

of

71

myelodysplastic syndromes : elevated

patients. Blood 79 (suppl):297a, 1990.

25. Elghetany MT, Molina CP, Patel J,

pyruvate kinase activity. Am J Hematol

Martinez J, Schwab H, Velagaleti GV :

30:97, 1989.
18. Breton Gorius J, Houssay D, Dreyfus

Epressions of CD4 on peripheral blood

B : Partial myeloperoidase deficiency in

case of preleukemia. I : studies of fine
structures and peroidase synthesis of
promyelocytes. Br J Haematol 30:273,
1975.
19. Dreyfus B, Sultan C, Rochant H, et al.:
Anomalies of blood group antigens and
erythrocyte enzyme in two types of
chronic

refractory

anaemia.

Br

Haematol 1:303, 1979.

20. Yoshida A, Kumazaki T, Dave V, Blank J,
Dzik WH: Suppressed epression of
blood group B antigen and blood group
galactocyltransferase in a pre leukaemic
subject. Blood 99:990, 1985
21. Uchida T, Kokubn K, Abe R, et al.:
Ferrokinetic

evaluations

erythropoiesis
myelodysplastic

in

of

patient

with

syndromes.

Acta

Haematol 79:81,1988.
22. Peters RE, May A, Jacobs A : Increased
Alpha:non-alpha globin chain synthesis
ratio in myelodysplastic syndromes and

granuloctes. A novel findings in a case

of

myelodysplastic

syndromes

in

associations with t (5;12). Cancer Genet

Cytogenet 139: 42,2002.
26. Elghetany MT, Peterson B, MacCallum
J, et al.: Deficiency of neutrophilic
granule membrane glycoprotein in the
myelodysplastic syndromes : a common
deficiency of 219 patients studied by the
cancer and leukaemia groups B. Leuk
Res 21:801-809,1997.
27. Elghetany MT, Peterson B, MacCallum J
et al.: Double esterase staining and
other neuthropilic granule abnormalities
in 273 patients with the myelodysplastic
syndromes studied by the cancer and
leukaemia

groups

B.Acta

Haematol

100:13-19,1998.
28. Breton-Gorious J, Houssay D, Dreyfus
B: Partial myeloperoidase deficiency in
a case of preleukaemia. I : Studied of
fine structures and peroidase synthesis
of

promyelocytes.

Br

Haematol

Pathol

30:273,1975.
29. Bauman MA, Keller RH, Mc Fadden

39:1233,1985.
23. Steensma DP, Gibbons RJ, Higgs DR :

PW, Libnoch JA, Patrick CW : Myeloid

myeloid

Acquired

leukaemia,

Chin

alpha-thalassemia

in

cell

surface

phenotype

in

myelodysplasia : evidence for abnormal

persistence

of

an

early

36. Russel NH, Keenan JP, Bellingham AJ:

myeloid

Thrombocytopathy in preleukaemia :

differentiation antigen. Am J Hematol

association with a defect of thromboane

22:251, 1987.
30. Calark RE, Smith SA, Jacobs A :

A2 activity: Br J Haematol 41: 417,

Myeloid surface antigen abnormalities in

1979.
37. Raman KS, Van Sylk EJ, Riddle J,

myelodysplasia: Relation to prognosis

Sawdyk MA, Abraham JP, SAeed SM :

and modification by 13-cis retinoic acid

Platelet

J.Clin.Pathol 40:952,1987.
31. Hokland P, Kerndrup G, Griffin JD,
Ellegaard

J:

Analysis

of

leucocyte

differentiation antigens in blood and

function

and

myeloproliverative

structures
disease

myelodysplastic

syndromes

in
,

and

secondary thrombocytosis . Am J Clin

praleukaemia

Pathol. 91:947, 1979.

38. Tuzuner N, Co C, Rowe J, Watrous D,

patients using monoclonal antibodies.

Bennet J: Hypocellular myelodysplastic

Blood 87:898, 1987.

32. Silverman LR, Yagi MJ, Holland JF,

syndromes : new proposals. Br J

bone

marrow

from

Bekesi JG : Lineage infidelity with

Haematol 91:912-917,1995.
39. Sorskaar D, Forre O, Alberstein D,

coepression of myeloid and lymphoid

Stavem P : Decreased natural killer cell

marker and IL-2 receptor are common in

activity versus normal natural killer cell

myelodysplastic syndromes. Proc. Am.

markers

Assoc. Can. Res. 33:152, 1992.

33. Felzman T , Gisslinger H, Krieger O,

in

mononuclear

cell

from

patients with smouldering leukaemia.

U:

Scand J Hematol 37:154,1987.

40. Merschav S, Nagler A, Silvian I, Carter

Immunophenotipic characterization of

A, Tatarsky I, Spira G: Immunoglobulin

myelomonocytic cell in patients with

synthesis

myelodysplastic

syndromes

Majdic

O,

Ludwig

H,

Koller

syndromes.

Br

HAematol 84: 428-435,1993.

34. Low GM, Dang Y, Watson F, Edwards

in
:

myelodisplastic

normal

cell

and

immunoregulatory T-cell functions . Clin

SW, Galvani DW: Identification of a

Immunol Immunopathol 42:195, 1987.

41. Mufti GJ, Figes A, Hamblin TJ, Oscier

subgroup of myelodysplastic syndromes

DG, Copplestone JA: Immunological

patients with a neutrophil stimulations

abnormalities

signaling defect. Br J Haematol 89-799,

syndromes. Br J Haematol 03:143,

1994.
35. Felman P, Bryon PA, Gentilhomme O, et

1987.
42. Sauntararajah Y, Nakamura R, Nam JM

al.: The syndrome of abnormalchromatin

et

clumping

overpressented

in

myelodysplastic

leucocytes
disorder

a
with

al.:

in

myelodysplastic

HLA-DR15
in

(DR2)

is

myelodysplastic

syndrome and aplastic anemia and

proliverative features. Br J Haematol 70:

predics

response

to

49-54, 1988.

immunosupression in myelodysplastic

syndromes.

Blood

100:1570-1574,

2002.
43. Mufti GJ, Figes A, Hamblin TJ, Oscier
DG,

Coppleston

abnormalities

T,

myelodysplastic

syndromes. J Autoimmune 19:77-89,

2001.
51. Prchal JT, Throckmorton DW, Carrol AJ,

myelodysplastic

Fusson EW, Gams RA: A common

syndromes . J CLin Pathol 38-908,

1985.
44. Economopolus

with

Immunological

JA:
in

patients

Economidou

J,

Giannopoulus

et

al.:

Immune

abnormalities

in

myelodysplastic

syndromes . J Clin Pathol 38:908, 1985.

45. Bosch, Bernadich O, Vera M: The

progenitor

for

human

myeloid

and

lymphoid cells. Science 274:590, 1978.

52. Ogata K, Nakamura K, Yokose N, et al.:
Clinical

significance

features

of

blast

myelodysplastic

of

in

phenotype

patients

syndromes

with
Blood

association between Crohn disease and

100:3887-3899,2002.
53. Kasahara S, Hara T, Itoh H et al.:

myelodysplastic syndromes. Report of 3

Hypoplastic myelodysplasia syndromes

cases and review of the literature.

can be distinguished from acquired

Medicine (Baltimore) 77:371-377, 1998.

46. Della Rossa A, Tavoni A, Tognetti A,

aplastic anemia by bone marrow stem

Testi

C,

Bombardieri

Disease

with

S:

Bechets

gastrointestinal

involvement in myelodysplastic in a
patients

with

panhypopytuarysm.

Clin

al.:Glomerular

myelodysplastic

Rheumatol

myelodysplastic

involvement

syndromes.

AG,

immunophenotyping

98:391-392, 2002.
55. Stetler-Stevenson

syndromes.
M,

Arthur

in
Blood
DC,

in

Jabbour N,et al.: Diagnostic utility of

Pediatri

flow cytometric immunophenotyping in

syndromes.

Am

Hematol 90-200204, 1999.

49. Giannoli S, Voulgareis M, Zintzaras E,
Tzioufas

2002.
54. Eighetany MT: Diagnoostic utility of flow
cytometric

Nephrol 19:1053-1057,2001.
48. Saitoh T, Murakami, Uchiumi, et al.:
Myelodysplastic

receptor. Br J Haematol 118:181-188,

congenital

17:515-517,1998.
47. Bagdanovic R, Kuzmanovic M, Markovic
et

ekspression of tumour necrosis factor

Moutsopoulus

HM:

myelodysplastic

syndromes.

Blood

98:979-987, 2001.
56. Miller DT, Stezer GT: Contributions of
flow cytometry to the analysis of the
myelodysplastic syndromes . Clin Lab

in

Med 21:811-828, 2001.

57. Ito S, Ishida, Muray K, Kuriya S: Flow

myelodysplastic syndromes : a 4 year

cytometric analysis of aberrant antigen

prospective

Rheumatology

epression of blasts using CD45 blast

(Oford) 43:929932, 2004.

50. Stahl D, Egreer G, Goldschmith H,

gating for minimal residual disease in

Autoimmune

phenomena
study.

Sibrowski W, Kazatzckine MD, Kaveri

SV: Altered self reactive antibody
repertoires are a general feature of

acute

leukaemia

and

high

risk

myelodysplastic syndromes. Leuk Res

25:205-211,2001.

58. Chang CC, Cleveland RP: Decreased

66. Maciewjewski JP Selleri C: Evolution of

CD10 positive mature granulocyte in

clonal cytogenetic of abnormalities in

bone

aplastic anemia. Leuk Lymphoma 45:

marrow

from

myelodysplastic

patients

syndromes.

with
Arch

Pathol Lab Med 124:1152-1159, 2000.

59. Sashida G, Takaku TI, Shoji N, et al.:
Clinico-haemathologic

features

of

myelodysplastic syndromes presenting

as isolated thrombocytopenia: an entity
with a relatively favorable prognostic.
Leuk Lymphoma 44:53-58, 2003.
60. Bain BJ: The Relationship between the
myelodysplastic syndromes and the
myeloproliverative

disorders,

Leuk

Lymphoma 34: 443-449, 1999.

61. Gupta R.Abdalla SH, Bain
Thrombocytosis

with

BJ:

sideroblastic

syndromes.

Leuk

Lymphoma 34:915-919, 1999.

62. Lamberthengi-Deliliers G, Annaloro C,
Oriani A, Soligo D: Myelodysplastic
syndromes

with

fibrosis:

distinc

increased

marrow

clinic-pathological

entity.Br J Haematol 78:191-199, 1991.

63. Lamberthengii Deililiers G Annaloro,
Oriani A, Soligo D: Myelodysplastic
syndromes

associated

with

bone

marrow fibrosis. Leuk Lymphoma 8:5155, 1992.

64. Maciewjewski JP, Risitano, Kook H,
Zeng W, Chen G, Young NS: Immune
pathophysiology of aplastic anemia Int J
Haematol 79 (suppl 1) :207-214, 2002.
65. Maciewjewski JP, Follman D, Nakamura
R, et al: Increased HLA DR2 in
patients

with

paroxysmal

nocturnal

hemoglobinuria and the PNH/aplastic

anemia

syndrome.

3519,2001.

Blood

Diagnosis

and

management of aplastic anemia and

myelodysplastic

syndrome.

Oncology

(Willston Park) 19:153-191,2002.

68. Maciewjewski JP, Selleri C: Evolution of
clonal

cytogenetic

abnormalities

in

aplastic anemia. Leuk Lymphoma 45:

443-440, 2004.
69. Saunthararajahh Y, Molldrem JL, Rivera
M, et al.: Coincident myelodysplastic
syndromes and T-cell large granular

erythropoiesis:a mied myeloproliperative

myelodysplastic

433-440, 2004.
67. Paquette
RL:

98:3513-

lymphocytic

disease:

pathophysiological

clinical

features.

Haematol 112:195-200,2001.

and
Br